Cosmetic Skin Safety & Patch Testing Explained (UK & EU)

Phrases like “dermatologically tested”, “suitable for sensitive skin” and “non-irritating” appear on cosmetics everywhere but you can only use them if you can back them up. That is where skin safety and patch testing come in. This guide explains what these human volunteer tests are, what they can and cannot prove, and when you actually need them.

Skin safety testing is one of the test types in our pillar guide to cosmetic lab testing. Here we focus on testing on people, done without any animal testing.

What is skin safety testing?

Skin-safety testing assesses how a finished product is tolerated on human skin whether it causes irritation or, over repeated exposure, sensitisation (an allergic response). It is carried out on human volunteers under controlled, ethical conditions by specialist providers, because animal testing of cosmetics is banned in the UK and EU. The aim is to confirm the product is well tolerated in real use and to support any tolerance related claims you wish to make.

These tests sit on top of the core safety assessment rather than replacing it. The CPSR already evaluates the product's safety from its ingredients and their known profiles; skin-safety studies add direct human tolerance evidence, which is particularly useful for products marketed on their gentleness.

Patch testing and repeat insult testing

A patch test applies a small amount of product to the skin under a patch and checks for a reaction over a short period a basic read on irritation. A more thorough study, the repeat insult patch test (HRIPT), applies the product repeatedly over several weeks to assess both irritation and the potential to cause sensitisation over time. The repeat-insult approach is more demanding and gives stronger evidence for tolerance claims because it mimics ongoing use rather than a single exposure.

These studies are run on panels of volunteers, with results assessed against established criteria. They are a recognised way to generate human-tolerance data ethically, and they are the kind of evidence that sits behind credible “dermatologically tested” type claims.

What 'dermatologically tested' really means

Claims such as “dermatologically tested”, “skin compatibility tested” or “suitable for sensitive skin” are claims, and like all cosmetic claims they must be truthful and supported by evidence. “Dermatologically tested” broadly indicates the product has undergone testing involving skin assessment, but on its own it is a modest claim it says testing happened, not that the product is guaranteed reaction free for everyone. Stronger claims about sensitive skin suitability need correspondingly stronger evidence.

The key compliance point is that you cannot put these phrases on a label decoratively. If you make a tolerance claim, you need the testing to back it; making it without evidence is a misleading claim. This connects to the wider rules on claims and labelling, where every statement must be substantiated.

In-use and consumer testing

Beyond patch testing, in use or consumer use studies ask volunteers to use the product normally over a period and report their experience, sometimes alongside expert assessment. These can support tolerance claims under real conditions and gather perception data how the product feels and performs in genuine use. They bridge the gap between a controlled patch test and the messy reality of everyday application.

Such studies are especially relevant for products making comfort, tolerance or performance claims, and for building consumer confidence. They are not a basic legal requirement for most products, but they are valuable where your marketing leans on how the product is experienced in use.

Is skin-safety testing required?

For most ordinary products, skin-safety testing on volunteers is not a basic legal requirement the mandatory route to market is a sound safety assessment and CPSR, which can often conclude a product is safe from ingredient data without dedicated human studies. Skin safety testing becomes necessary when you want to make specific tolerance claims, or where a product's nature or ingredients make direct human tolerance evidence valuable to support the safety conclusion.

So the honest answer mirrors the wider testing picture: it depends on your product and, especially, your claims. If you intend to market on gentleness or sensitive-skin suitability, plan for the testing that supports those words. If you do not make such claims, you may not need it your assessor can advise.

Planning testing into your launch timeline

Skin-safety and in-use studies take time a repeat-insult patch test runs over several weeks, and in-use studies longer still so they have to be planned into your launch schedule rather than bolted on at the end. A common and painful mistake is finalising packaging and marketing around a “suitable for sensitive skin” claim, then discovering the supporting study cannot be completed before the intended launch date. Working backwards from launch, with testing slotted in early, avoids this trap.

It also pays to decide your claims before you test, not after. The claim you want to make determines the study you need, so settling your marketing message early lets you commission the right testing once. Deciding late, or changing the claim after testing, can mean paying for a study that does not match your final wording or having to run another.

As with the rest of your compliance, the smoothest path is to involve your safety assessor at the planning stage. They can tell you which claims need which evidence, how long each study takes, and how it all fits with your CPSR so testing supports your launch instead of delaying it. Treating testing as part of the project plan, rather than a last-minute hurdle, keeps both your timeline and your claims intact.

Skin-safety testing checklist

• Match testing to the claims you want to make.

• Use patch or repeat-insult (HRIPT) studies for tolerance evidence.

• Remember all testing is on volunteers, never animals.

• Don't use “dermatologically tested” type phrases without evidence.

• Consider in-use studies for comfort and performance claims.

• Confirm with your assessor what your product actually needs.

Frequently asked questions

What is cosmetic patch testing?

A test that applies product to the skin under a patch to check for a reaction. A repeat insult patch test (HRIPT) applies it repeatedly over weeks to assess irritation and sensitisation potential, giving stronger tolerance evidence.

Does 'dermatologically tested' guarantee no reaction?

No. It broadly indicates the product underwent testing involving skin assessment. It does not guarantee it is reaction-free for everyone, and stronger sensitive-skin claims need stronger evidence.

Is skin-safety testing legally required?

For most ordinary products, not as a basic requirement a sound CPSR can often conclude safety from ingredient data. It becomes necessary to support specific tolerance claims or where human-tolerance evidence is valuable.

Is any of this tested on animals?

No. Animal testing of cosmetics and ingredients is banned in the UK and EU. Skin-safety testing uses human volunteers under controlled, ethical conditions.

What's the difference between patch testing and in use testing?

Patch testing applies product under controlled patch conditions to check tolerance; in-use studies have volunteers use the product normally over time to support real world tolerance and performance claims.

How long does skin-safety testing take?

A repeat insult patch test runs over several weeks and in-use studies longer, so they must be planned into your launch timeline early rather than added at the end.

Should I decide my claims before testing?

Yes. The claim you want to make determines the study you need, so settling your marketing wording first lets you commission the right testing once instead of paying for a study that doesn't match your final claim.

References: Regulation (EC) No 1223/2009, Articles 18 and 20 (EUR-Lex); EU ban on animal testing for cosmetics; UK Cosmetics Regulation as retained; claims substantiation guidance. General information only, not legal advice.